Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 55

    1.

    Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era.

    Champlin R, de Lima M, Kebriaei P, Rondon G, Fisher T, Jabbour E, Cortés JE, Kantarjian H, Anderlini P, Alousi A, Hosing C, Shpall E, Popat U, Qazilbash M, Andersson B, Giralt S.

    Clin Lymphoma Myeloma. 2009;9 Suppl 3:S261-5.PMID: 19778850 [PubMed - in process]Related articles

    2.

    Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fraction.

    Qazilbash MH, Amjad AI, Qureshi S, Qureshi SR, Saliba RM, Khan ZU, Hosing C, Giralt SA, De Lima MJ, Popat UR, Yusuf SW, Champlin RE.

    Biol Blood Marrow Transplant. 2009 Oct;15(10):1265-70. Epub 2009 Aug 3.PMID: 19747634 [PubMed - in process]Related articles

    3.

    Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation.

    de Souza JA, Saliba RM, Patah P, Rondon G, Ribeiro R, de Padua Silva L, Qazilbash MH, Hosing C, Popat U, Efebera Y, Champlin RE, de Lima M.

    Biol Blood Marrow Transplant. 2009 Sep;15(9):1094-9.PMID: 19660722 [PubMed - indexed for MEDLINE]Related articles

    4.

    Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease.

    Parmar S, Del Lima M, Zou Y, Patah PA, Liu P, Cano P, Rondon G, Pesoa S, de Padua Silva L, Qazilbash MH, Hosing C, Popat U, Kebriaei P, Shpall EJ, Giralt S, Champlin RE, Stastny P, Fernandez-Vina M.

    Blood. 2009 Oct 1;114(14):2884-7. Epub 2009 Aug 4.PMID: 19654407 [PubMed - in process]Related articles

    5.

    Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma.

    Parikh GC, Amjad AI, Saliba RM, Kazmi SM, Khan ZU, Lahoti A, Hosing C, Mendoza F, Qureshi SR, Weber DM, Wang M, Popat U, Alousi AM, Champlin RE, Giralt SA, Qazilbash MH.

    Biol Blood Marrow Transplant. 2009 Jul;15(7):812-6.PMID: 19539212 [PubMed - indexed for MEDLINE]Related articles

    6.

    Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.

    Popat U, Saliba R, Thandi R, Hosing C, Qazilbash M, Anderlini P, Shpall E, McMannis J, Körbling M, Alousi A, Andersson B, Nieto Y, Kebriaei P, Khouri I, de Lima M, Weber D, Thomas S, Wang M, Jones R, Champlin R, Giralt S.

    Biol Blood Marrow Transplant. 2009 Jun;15(6):718-23. Epub 2009 Apr 8.PMID: 19450756 [PubMed - indexed for MEDLINE]Related articles

    7.

    Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma.

    Hosing C, Saliba RM, Ahlawat S, Körbling M, Kebriaei P, Alousi A, De Lima M, Okoroji JG, McMannis J, Qazilbash M, Anderlini P, Giralt S, Champlin RE, Khouri I, Popat U.

    Am J Hematol. 2009 Jun;84(6):335-7.PMID: 19384931 [PubMed - indexed for MEDLINE]Related articles

    8.

    Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma.

    Tam CS, Bassett R, Ledesma C, Korbling M, Alousi A, Hosing C, Kebraei P, Harrell R, Rondon G, Giralt SA, Anderlini P, Popat U, Pro B, Samuels B, Hagemeister F, Medeiros LJ, Champlin RE, Khouri IF.

    Blood. 2009 Apr 30;113(18):4144-52. Epub 2009 Jan 23.PMID: 19168784 [PubMed - indexed for MEDLINE]Related articles

    9.

    Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

    Ramos CA, Saliba RM, de Pádua L, Khorshid O, Shpall EJ, Giralt S, Patah PA, Hosing CM, Popat UR, Rondon G, Khouri IF, Nieto YL, Champlin RE, de Lima M.

    Haematologica. 2009 Feb;94(2):249-57. Epub 2009 Jan 14.PMID: 19144658 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial.

    Qazilbash MH, Saliba RM, Nieto Y, Parikh G, Pelosini M, Khan FB, Jones RB, Hosing C, Mendoza F, Weber DM, Wang M, Popat U, Alousi A, Anderlini P, Champlin RE, Giralt S.

    Biol Blood Marrow Transplant. 2008 Dec;14(12):1401-7.PMID: 19041063 [PubMed - indexed for MEDLINE]Related articles

    11.

    Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis.

    Appel SH, Engelhardt JI, Henkel JS, Siklos L, Beers DR, Yen AA, Simpson EP, Luo Y, Carrum G, Heslop HE, Brenner MK, Popat U.

    Neurology. 2008 Oct 21;71(17):1326-34.PMID: 18936424 [PubMed - indexed for MEDLINE]Related articles

    12.

    The natural history and treatment outcome of blast phase BCR-ABL- myeloproliferative neoplasms.

    Tam CS, Nussenzveig RM, Popat U, Bueso-Ramos CE, Thomas DA, Cortes JA, Champlin RE, Ciurea SE, Manshouri T, Pierce SM, Kantarjian HM, Verstovsek S.

    Blood. 2008 Sep 1;112(5):1628-37. Epub 2008 Jun 19.PMID: 18566326 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation.

    Alousi AM, Saliba RM, Okoroji GJ, Macapinlac HA, Hosing C, Korbling M, Samuels BI, Popat U, Kebriaei P, Anderlini P, Qazilbash MH, de Lima M, Giralt SA, Champlin RE, Khouri IF.

    Br J Haematol. 2008 Sep;142(5):786-92. Epub 2008 Jun 17.PMID: 18564354 [PubMed - indexed for MEDLINE]Related articles

    14.

    Angiogenesis in pulmonary hypertension with myelofibrosis.

    Zetterberg E, Popat U, Hasselbalch H, Prchal J, Palmblad J.

    Haematologica. 2008 Jun;93(6):945-6. Epub 2008 May 6. No abstract available. PMID: 18460649 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age.

    Hosing C, Saliba RM, Okoroji GJ, Popat U, Couriel D, Ali T, De Padua Silva L, Kebriaei P, Alousi A, De Lima M, Qazilbash M, Anderlini P, Giralt S, Champlin RE, Khouri I.

    Ann Oncol. 2008 Jun;19(6):1166-71. Epub 2008 Feb 13.PMID: 18272911 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Autologous HSCT for advanced MS: is the glass half-empty or really half-full?

    Nash RA, Stuve O, Bowen JD, Frohman EM, Griffith LM, Hutton GJ, Kraft GH, Popat U, Racke MK, Muraro PA.

    Brain. 2008 Feb;131(Pt 2):e89; author reply e90. Epub 2007 Sep 30. No abstract available. PMID: 17908695 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplant.

    Qazilbash MH, Saliba RM, Ahmed B, Parikh G, Mendoza F, Ashraf N, Hosing C, Flosser T, Weber DM, Wang M, Couriel DR, Popat U, Kebriaei P, Alousi AM, Anderlini P, Naeem RC, Champlin RE, Giralt SA.

    Biol Blood Marrow Transplant. 2007 Sep;13(9):1066-72. Epub 2007 Jul 16.PMID: 17697969 [PubMed - indexed for MEDLINE]Related articles

    18.

    Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation.

    Oran B, Giralt S, Couriel D, Hosing C, Shpall EJ, de Meis E, Khouri IF, Qazilbash M, Anderlini P, Kebriaei P, Popat U, Carrasco-Yalan A, Champlin RE, de Lima M.

    Leukemia. 2007 Dec;21(12):2540-4. Epub 2007 Jul 5. No abstract available. PMID: 17611563 [PubMed - indexed for MEDLINE]Related articles

    19.

    Marrow fibrosis does not account for circulating CD34+ cells in myelofibrosis with myeloid metaplasia.

    Samuelson SJ, Popat U, Prchal JT.

    Haematologica. 2007 Apr;92(4):e47. No abstract available. PMID: 17405759 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment.

    Oran B, Donato M, Aleman A, Hosing C, Korbling M, Detry MA, Wei C, Anderlini P, Popat U, Shpall E, Giralt S, Champlin RE.

    Biol Blood Marrow Transplant. 2007 Apr;13(4):469-77. Epub 2007 Feb 8.PMID: 17382253 [PubMed - indexed for MEDLINE]Related articles

    21.

    Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan.

    Oran B, Giralt S, Saliba R, Hosing C, Popat U, Khouri I, Couriel D, Qazilbash M, Anderlini P, Kebriaei P, Ghosh S, Carrasco-Yalan A, de Meis E, Anagnostopoulos A, Donato M, Champlin RE, de Lima M.

    Biol Blood Marrow Transplant. 2007 Apr;13(4):454-62. Epub 2007 Feb 8.PMID: 17382251 [PubMed - indexed for MEDLINE]Related articles

    22.

    Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma.

    Qazilbash MH, Saliba RM, Hosing C, Mendoza F, Qureshi SR, Weber DM, Wang M, Flosser T, Couriel DR, De Lima M, Kebriaei P, Popat U, Alousi AM, Champlin RE, Giralt SA.

    Bone Marrow Transplant. 2007 Mar;39(5):279-83. Epub 2007 Jan 29.PMID: 17262062 [PubMed - indexed for MEDLINE]Related articles

    23.

    Idiopathic myelofibrosis without dacryocytes.

    Chen GL, Liu E, Naidoo K, Popat U, Coetzer TL, Prchal JT.

    Haematologica. 2006 Jun;91(6 Suppl):ECR29.PMID: 16785132 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma.

    Hosing C, Qazilbash MH, Kebriaei P, Giralt S, Davis MS, Popat U, Anderlini P, Shpall EJ, McMannis J, Körbling M, Champlin RE.

    Br J Haematol. 2006 Jun;133(5):533-7.PMID: 16681642 [PubMed - indexed for MEDLINE]Related articles

    25.

    Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation (RISCT) using antilymphocyte antibodies in patients with high-risk acute myeloid leukemia (AML).

    Popat U, Heslop HE, Durett A, May R, Krance RA, Brenner MK, Carrum G.

    Bone Marrow Transplant. 2006 Mar;37(6):547-52.PMID: 16462757 [PubMed - indexed for MEDLINE]Related articles

    26.
    27.

    Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?

    Couriel D, Hosing C, Saliba R, Shpall EJ, Andelini P, Popat U, Donato M, Champlin R.

    Biol Blood Marrow Transplant. 2006 Jan;12(1 Suppl 2):37-40.PMID: 16399600 [PubMed - indexed for MEDLINE]Related articles

    28.

    Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation.

    Rousseau RF, Biagi E, Dutour A, Yvon ES, Brown MP, Lin T, Mei Z, Grilley B, Popek E, Heslop HE, Gee AP, Krance RA, Popat U, Carrum G, Margolin JF, Brenner MK.

    Blood. 2006 Feb 15;107(4):1332-41. Epub 2005 Oct 25.PMID: 16249392 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia.

    Biagi E, Rousseau R, Yvon E, Schwartz M, Dotti G, Foster A, Havlik-Cooper D, Grilley B, Gee A, Baker K, Carrum G, Rice L, Andreeff M, Popat U, Brenner M.

    Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6916-23.PMID: 16203783 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    New onset of myelofibrosis in association with pulmonary arterial hypertension.

    Popat U, Frost A, Liu E, May R, Bag R, Reddy V, Prchal JT.

    Ann Intern Med. 2005 Sep 20;143(6):466-7. No abstract available. PMID: 16172450 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab.

    Lamba R, Carrum G, Myers GD, Bollard CM, Krance RA, Heslop HE, Brenner MK, Popat U.

    Bone Marrow Transplant. 2005 Nov;36(9):797-802.PMID: 16151431 [PubMed - indexed for MEDLINE]Related articles

    32.

    Hematopoietic stem cell transplantation for multiple sclerosis.

    Burt RK, Cohen B, Rose J, Petersen F, Oyama Y, Stefoski D, Katsamakis G, Carrier E, Kozak T, Muraro PA, Martin R, Hintzen R, Slavin S, Karussis D, Haggiag S, Voltarelli JC, Ellison GW, Jovanovic B, Popat U, McGuirk J, Statkute L, Verda L, Haas J, Arnold R.

    Arch Neurol. 2005 Jun;62(6):860-4. Review. No abstract available. PMID: 15956156 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    CD52 and CD45 monoclonal antibodies for reduced intensity hemopoietic stem cell transplantation from HLA matched and one antigen mismatched unrelated donors.

    Popat U, Carrum G, May R, Lamba R, Krance RA, Heslop HE, Brenner MK.

    Bone Marrow Transplant. 2005 Jun;35(12):1127-32.PMID: 15834432 [PubMed - indexed for MEDLINE]Related articles

    34.

    Constitutive mobilization of CD34+ cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteases.

    Xu M, Bruno E, Chao J, Huang S, Finazzi G, Fruchtman SM, Popat U, Prchal JT, Barosi G, Hoffman R; MPD Research Consortium.

    Blood. 2005 Jun 1;105(11):4508-15. Epub 2005 Feb 10.PMID: 15705794 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia.

    Rondelli D, Barosi G, Bacigalupo A, Prchal JT, Popat U, Alessandrino EP, Spivak JL, Smith BD, Klingemann HG, Fruchtman S, Hoffman R; Myeloproliferative Diseases-Research Consortium.

    Blood. 2005 May 15;105(10):4115-9. Epub 2005 Jan 25.PMID: 15671439 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Every case of essential thrombocythemia should be tested for the Philadelphia chromosome.

    Rice L, Popat U.

    Am J Hematol. 2005 Jan;78(1):71-3.PMID: 15609281 [PubMed - indexed for MEDLINE]Related articles

    37.

    Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes.

    Straathof KC, Bollard CM, Popat U, Huls MH, Lopez T, Morriss MC, Gresik MV, Gee AP, Russell HV, Brenner MK, Rooney CM, Heslop HE.

    Blood. 2005 Mar 1;105(5):1898-904. Epub 2004 Nov 12.PMID: 15542583 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Molecular transfer of CD40 and OX40 ligands to leukemic human B cells induces expansion of autologous tumor-reactive cytotoxic T lymphocytes.

    Biagi E, Dotti G, Yvon E, Lee E, Pule M, Vigouroux S, Gottschalk S, Popat U, Rousseau R, Brenner M.

    Blood. 2005 Mar 15;105(6):2436-42. Epub 2004 Nov 9.PMID: 15536147 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis.

    Xu M, Bruno E, Chao J, Ni H, Lindgren V, Nunez R, Mahmud N, Finazzi G, Fruchtman SM, Popat U, Liu E, Prchal JT, Rondelli D, Barosi G, Hoffman R.

    Blood. 2005 Feb 15;105(4):1699-705. Epub 2004 Oct 7.PMID: 15471948 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Haematopoietic stem cell transplantation for autoimmune disorders: the American perspective.

    Popat U, Krance R.

    Br J Haematol. 2004 Sep;126(5):637-49. Review.PMID: 15327514 [PubMed - indexed for MEDLINE]Related articles

    41.

    Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.

    Popat U, Hosing C, Saliba RM, Anderlini P, van Besien K, Przepiorka D, Khouri IF, Gajewski J, Claxton D, Giralt S, Rodriguez M, Romaguera J, Hagemeister F, Ha C, Cox J, Cabanillas F, Andersson BS, Champlin RE.

    Bone Marrow Transplant. 2004 May;33(10):1015-23.PMID: 15048145 [PubMed - indexed for MEDLINE]Related articles

    42.

    Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis.

    Sun W, Popat U, Hutton G, Zang YC, Krance R, Carrum G, Land GA, Heslop H, Brenner M, Zhang JZ.

    Brain. 2004 May;127(Pt 5):996-1008. Epub 2004 Feb 25.PMID: 14985264 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Transfusion-related acute lung injury (TRALI) following allogeneic stem cell transplant for acute myeloid leukemia.

    Ganguly S, Carrum G, Nizzi F, Heslop HE, Popat U.

    Am J Hematol. 2004 Jan;75(1):48-51.PMID: 14695632 [PubMed - indexed for MEDLINE]Related articles

    44.

    Small-cell cancers, and an unusual reaction to chemotherapy. Case 2. Synchronous renal cell carcinoma and limited-stage small-cell lung cancer.

    Massarweh S, Lewitton M, Popat U, Lynch GR.

    J Clin Oncol. 2003 Jun 15;21(12):2439-40. No abstract available. PMID: 12805345 [PubMed - indexed for MEDLINE]Related articles

    45.

    Bystander transfer of functional human CD40 ligand from gene-modified fibroblasts to B-chronic lymphocytic leukemia cells.

    Biagi E, Yvon E, Dotti G, Amrolia PJ, Takahashi S, Popat U, Marini F, Andreeff M, Brenner MK, Rousseau RF.

    Hum Gene Ther. 2003 Apr 10;14(6):545-59.PMID: 12718765 [PubMed - indexed for MEDLINE]Related articles

    46.

    Haemopoietic stem cell transplantation for acute lymphoblastic leukaemia.

    Popat U, Carrum G, Heslop HE.

    Cancer Treat Rev. 2003 Feb;29(1):3-10. Review.PMID: 12633575 [PubMed - indexed for MEDLINE]Related articles

    47.

    Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease.

    Heslop H, Rooney C, Brenner M, Krance R, Carrum G, Gahn B, Bollard C, Khan S, Gee A, Popat U, Gresik M, Przepiorka D, Kuehnle I, Grilley B.

    Hum Gene Ther. 2000 Jul 1;11(10):1465-75. No abstract available. PMID: 10910143 [PubMed - indexed for MEDLINE]Related articles

    48.

    High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.

    Popat U, Przepiork D, Champlin R, Pugh W, Amin K, Mehra R, Rodriguez J, Giralt S, Romaguera J, Rodriguez A, Preti A, Andersson B, Khouri I, Claxton D, de Lima M, Donato M, Anderlini P, Gajewski J, Cabanillas F, van Besien K.

    J Clin Oncol. 1998 Jan;16(1):63-9.PMID: 9440724 [PubMed - indexed for MEDLINE]Related articles

    49.

    Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia.

    Choudhury A, Gajewski JL, Liang JC, Popat U, Claxton DF, Kliche KO, Andreeff M, Champlin RE.

    Blood. 1997 Feb 15;89(4):1133-42.PMID: 9028934 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Idiopathic myelofibrosis in children.

    Sekhar M, Prentice HG, Popat U, Anderson D, Janmohammed R, Roberts I, Britt RP.

    Br J Haematol. 1996 May;93(2):394-7.PMID: 8639435 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...